Peter Hayes

The National College Athletic Association shook off a proposed civil rights class action, which alleged its academic eligibility criteria for Division I sports discriminate against student-athletes at historically Black colleges and universities.

Health Network Laboratories LP has settled claims that it interfered with a technician’s medical leave by firing her for helping her husband with his meal preparation business while she was on leave during the Covid-19 pandemic.

Trader Joe’s Co. asked a federal trial court to greenlight its trademark infringement claims over merchandise sold online by the union representing some of its employees.

A Catholic medical center is temporarily shielded from a Colorado law that bars medical professionals from helping pregnant people reverse pill-induced abortions using progesterone while its suit challenging the measure goes forward.

“E-Cigarette Liquid Makers Win Review of FDA Product Block; Agency violated fair notice doctrine, 5th Cir. majority says; Dissenting judges say FDA’s position hasn’t changed”:

Financial software company Intuit Inc. hit H&R Block Inc. with a lawsuit in the Northern District of California, alleging the company is engaged in “false and misleading marketing” in an effort to “tarnish TurboTax’s hard-earned reputation in the online tax-preparation space.”

Maine health officials shook off a challenge to the state's mandatory Covid-19 vaccination rule for health-care employees after a federal trial court found the claims are moot.

Nick Kizrnis returned to Kaleidoscope in advance of the May 1 release of his new album, Every Moment. The singer and guitarist performed songs from the forthcoming album live in WYSO’s studios, and spoke with WYSO music director Juliet Fromholt about conceiving the project during a period of global–and personal–turmoil. He also talked about how vocal coaching from Kate Wakefield, lead singer and cellist of Lung, helped him find his singing voice. He told Juliet, “I discovered everything new about my voice.”

A women’s professional networking company, National Association of Professional Women, is liable for failing to pay overtime and willful violation of federal and New York labor laws in a class and collective action brought by sales representatives, a federal trial court ruled.

Background and aims Pre-emptive transjugular intrahepatic portosystemic shunt (pTIPSS) within 72 hours following acute oesophageal variceal bleeding has potential survival benefit. However, there is uncertainty whether pTIPSS is advantageous over standard of care (SOC) and long-term outcomes remain unstudied.Approach Patients recruited to a Scottish randomised control trial were allocated to SOC or pTIPSS and had follow-up extended to 3 years. The primary outcome was 3-year transplant-free survival on intention to treat and per-protocol analysis.Results 58 patients were initially recruited, 29 patients per group. Of the 29 in the pTIPSS group, only 23 received TIPSS placement due to logistical reasons. On intention to treat analysis, 3-year transplant-free survival rate in the SOC group was significantly higher than that of the pTIPSS group (55.2% vs 20.1%, p=0.006, HR 2.5, 95% CI 1.3 to 4.87). On per-protocol analysis, 3-year transplant-free survival rate in the SOC group was significantly higher than that of the pTIPSS group (55.2% vs 15.4%, p=0.03, HR 2.93, 95% CI 1.27 to 7.94). There were significantly higher rates of sepsis-related death or sepsis-induced liver failure-related death in the pTIPSS group compared with the SOC group (48.2% vs 3.6%, p<0.001, reciprocal of RR 13.0, 95% CI 2.46 to 75.45). There were no differences in other outcomes associated with portal hypertension on intention to treat analysis.Conclusion pTIPSS was associated with significantly reduced rates of transplant-free survival at 3 years compared with SOC. This may be due to higher rates of sepsis. Further large studies are required to validate these findings.All data relevant to the study are included in the article or uploaded as supplementary information.